Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 8, 2013, Pages 4853-4858

  Li, Da Wei ^a   Dong, Pin ^b   Wang, Fei ^b   Chen, Xin Wei ^b   Xu, Cheng Zhi ^c   Zhou, Liang ^a  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cell hypoxia; Drug resistance, multiple; Hypoxia inducible factor 1 ; Laryngeal neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PACLITAXEL; SMALL INTERFERING RNA;

ANOXIA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; FLOW CYTOMETRY; GENETICS; HUMAN; LARYNX TUMOR; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANOXIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LARYNGEAL NEOPLASMS; PACLITAXEL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84885763308     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.8.4853     Document Type: Article

References (22)

1. Chou CW, Wang CC, Wu CP, et al (2012). Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1. Neuro Oncol, 14, 1227-38.
2. Chu EA, Kim YJ (2008). Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am, 41, 673-95.
3. Huang L, Ao Q, Zhang Q, et al (2010). Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. J Cancer Res Clin Oncol, 136, 447-56.
4. Huang S, Peng L, Tang Y, et al (2013). Hypoxia of PC-3 prostate cancer cells enhances migration and vasculogenesis in vitro of bone marrow-derived endothelial progenitor cells by secretion of cytokines. Oncol Rep, 29, 2369-77.
5. Jing SW, Wang YD, Kuroda M, et al (2012). HIF-1a contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Acta Med Okayama, 66, 399-407.
6. Li DW, Zhou L, Jin B, et al (2013). Expression and significance of hypoxia-inducible factor-1a and survivin in laryngeal carcinoma tissue and cells. Otolaryngol Head Neck Surg, 148, 75-81.
7. Li L, Jiang AC, Dong P, et al (2007). The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg, 137, 659-64.
8. Liu L, Ning X, Sun L, et al (2008). Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci, 99, 121-8.
9. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.
10. Li Y, Ye D (2010). Cancer therapy by targeting hypoxia-inducible factor-1. Curr Cancer Drug Targets, 10, 782-96.
11. O'Donnell JL, Joyce MR, Shannon AM, et al (2006). Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev, 32, 407-16.
12. Park SY, Jang WJ, Yi EY, et al (2010). Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res, 48, 178-84.
13. Schrijvers ML, van der Laan BF, de Bock GH (2008). Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glotticlaryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys, 72, 161-9.
14. Sowter HM, Raval RR, Moore JW (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res, 63, 6130-4.
15. Tak E, Lee S, Lee J, et al (2011). Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. J Hepatol, 54, 328-39.
16. Thews O, Nowak M, Sauvant C, Gekle M (2011). Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway. Adv Exp Med Biol, 701, 115-22.
17. Wang GL, Jiang BH, Rue EA, Semenza GL (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 92, 5510-4.
18. Wohlkoenig C, Leithner K, Deutsch A, et al (2011). Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells. Cancer Lett, 308, 134-43.
19. Wu XH, Lu YF, Hu XD, et al (2010). Expression of hypoxia inducible factor-1a and its significance in laryngeal carcinoma. J Int Med Res, 38, 2040-6.
20. Yoshiba S, Ito D, Nagumo T, et al (2009). Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol, 45, 109-15.
21. Zhang L, Huang G, Li X, et al (2013). Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1a in hepatocellular carcinoma. BMC Cancer, 13, 108.
22. Zhu H, Chen XP, Luo SF, et al (2005). Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res, 24, 565-74.